References
Subramanian G, Cohen HV, Quek SYP (2011) A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide’s potential role in its resolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(6):744–753
Harper RP, Fung E (2007) Resolution of biphosphonate-associated osteonecrosis of the mandible: possible application for intermitent low-dose parathyroid hormone [rhPTH(1-34)]. J Oral Maxillofac Surg 65:573–580
Lau AN, Adachi JD (2009) Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy. J Rheumatol 36:1835–1837
Cheung A, Seeman E (2010) Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. N Engl J Med 363:2473–2474
Lee JJ, Cheng SJ, Jeng JH, Chiang CP, Lau HP, Kok SH et al (2011) Successful treatment of advanced biphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy. Head Neck 33(9):1366–1371. doi:10.1002/hed.21758
Narongroeknawin P, Danila MI, Humphreys LG Jr, Barasch A, Curtis JR (2010) Bisphosphonate-associated osteonecrosis of the jaw with healing after teriparatide: a review of the literature and a case report. Spec Care Dentist 30:77–82
Tsai KY, Huang CS, Huang GM, Yu CT (2010) More on the resolution of biphosphonate-associated osteonecrosis of the jaw. J Rheumatol 37:675
Geara AS, Castellanos MR, Bassil C, Schuller-Levis G, Park E, Smith M et al (2010) Effects of parathyroid hormone on immune function. Clin Dev Immunol. 2010, pii: 418695
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Narváez, J., Narváez, J.A., Gómez-Vaquero, C. et al. Lack of response to teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw. Osteoporos Int 24, 731–733 (2013). https://doi.org/10.1007/s00198-012-1918-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-012-1918-9